Status:
RECRUITING
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
Lead Sponsor:
Centre Henri Becquerel
Conditions:
Squamous Cell Carcinoma of Head and Neck
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Post-operative concomitant radiochemotherapy is a treatment that is difficult to achieve for several reasons. First of all, and by definition, these patients have had recent surgery, most often accomp...
Eligibility Criteria
Inclusion
- Male or female, over 18 and under 75 years of age,
- Worl Health Organisation score \< 2,
- Treatment for a localized squamous cell carcinoma of the head and neck for which a curative treatment by concomitant post-operative radiochemotherapy based on cisplatin is retained,
- Having signed the informed consent,
- Affiliate or beneficiary of a social protection scheme.
Exclusion
- History of other neoplastic disease less than 2 years old or progressive,
- History of radiotherapy for head and neck cancer,
- Contraindications to cisplatin,
- Pregnant or breastfeeding woman,
- Protected major (under guardianship or curatorship),
- Patient participating in a therapeutic study
- Patient unable to understand the study for any reason or to comply with the constraints of the trial
Key Trial Info
Start Date :
November 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04528420
Start Date
November 26 2020
End Date
June 1 2028
Last Update
January 2 2026
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France
2
CH Beauvais
Beauvais, France
3
Clinique du Parc
Caen, France
4
Centre Guillaume le Conquérant
Le Havre, France